← All candidates
Six insider buys in the last year — $495.2K in all.
39 filings on record.
CECelanese Corp
NYSE · Basic Materials · $5.13B
$44.78
+5.45% · Sep 15
Six insider buys in the last year — $495.2K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 6 buys◆ 12 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$5.13B
Float
99.8M
91% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
7.6
Price / sales
0.5
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
SVP & CFO
Kyrish Chuck
Bought $205.2K on Dec 9 — 5,000 sh @ $41.03, held direct, 46% of their stake.
1 of 1 position beat the S&P
CEO & President
Richardson Scott A
Bought $158.0K on Dec 10 — 3,800 sh @ $41.59, held direct, 5.4% of their stake.
1 of 1 position beat the S&P
Director
Galante Edward G
Bought $99.1K on Aug 14 — 2,400 sh @ $41.27, held direct, 11% of their stake.
1 of 1 position beat the S&P
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
28 more transactions on Pro →Context
Wall St
$67.50 avg target
+50.7% vs today · 16 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
2 of 4 quarters beat
Q1 '26$0.85 act−$0.05
Q4 '25$0.67 act−$0.24
Q3 '25$1.34 act+$0.12
Q2 '25$1.44 act+$0.04
Coverage
Celanese (CE) Reports Next Week: Wall Street Expects Earnings GrowthZacks · 07-28Celanese (CE) Could Be 34% Undervalued Following Its Latest Dividend UpdateSimply Wall St. · 07-20Celanese (CE) Stock Looks Undervalued On Sales But Weak On Share PriceSimply Wall St. · 07-20Celanese Sees Mixed Investor Sentiment With Commodity Chemicals Sector 'Out of Favor,' Morgan Stanley SaysMT Newswires · 07-16
The file stays open
39 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice